DEREK J MAETZOLD

CIK 1239501 · Pres. & Chief Exec. Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.34M

Companies

2

Total Filings

189

Lifetime Open-Market Net

-$91.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CSTL Pres. & Chief Exec. Officer 64,601 $20.70 $1.34M -$91.13M 185 2026-06-03
ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted V.P., Marketing & Sales 0 $0 4 2008-04-03

Recent Filings · Page 11 of 19

189 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-09-14 CSTL Sell (S) −8,999 -$262.5K EDGAR
2022-08-31 CSTL Sell (S) −10,359 -$306.1K EDGAR
2022-08-17 CSTL Sell (S) −18,931 -$624.7K EDGAR
2022-08-17 CSTL Sell (S) −36 -$1.2K EDGAR
2022-08-09 CSTL Sell (S) −1,558 -$47.2K EDGAR
2022-08-05 CSTL Sell (S) −8,450 -$259.6K EDGAR
2022-08-03 CSTL Sell (S) −8,959 -$245.7K EDGAR
2022-04-28 CSTL Grant (A) +22,311 $0 EDGAR
2022-01-20 CSTL Gift (G) −122,181 $0 EDGAR
2021-12-14 CSTL Mixed +3,252 -$85.5K EDGAR
Showing 101110 of 189
Page 11 of 19
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.